Dr Reddys Laboratories Share Price Today - Live Blog for April 08, 2025

Dr Reddys Laboratories Ltd's stock has surged by 0.23%, and it is currently trading at ₹1,108.70. Additionally, the stock maintains a PE ratio of 16.9100, while the industry PE is 33.0184.

Dr Reddys Laboratories Ltd's shares experienced a 0.08% uptick, and they are currently valued at ₹1,109.40, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

The stock of Dr Reddys Laboratories Ltd suffered a -0.20% decline, and it currently trades at ₹1,107.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.28%, and as of now, it's trading at ₹1,111.75 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd observed a -0.18% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,108.00. The stock has a PE ratio of 16.9100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's shares experienced a 0.12% uptick, and they are currently valued at ₹1,108.20, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd observed a remarkable 0.12% surge in its share price and is presently trading at ₹1,108.20. The increased investor interest is driving this surge.

The stock of Dr Reddys Laboratories Ltd suffered a -0.23% decline, and it currently trades at ₹1,110.45 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price has fallen by -0.23%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,110.45, and market participants are assessing the implications. The stock has a PE ratio of 16.9100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Demonstrating a commendable 0.09% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,112.85. In terms of valuation, the stock maintains a PE ratio of 16.9100, while the industry PE ratio stands at 33.0184.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.23%, reaching the current market price of ₹1,111.05. This development underscores the stock's growing popularity.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.18%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,109.85 per share.

Dr Reddys Laboratories Ltd experienced a substantial 0.18% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,109.85, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's stock price surged by 0.10%, reaching the current market value of ₹1,108.35 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.10% upswing, and it's currently trading at ₹1,108.35 per share. Investors are closely watching this development.

The stock of Dr Reddys Laboratories Ltd is facing a -0.05% decline and is currently trading at ₹1,107.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

There were no alterations in the share price of Dr Reddys Laboratories Ltd, and it is currently trading at ₹1,107.25. The stock has a PE ratio of 16.9100, an ROE of 17.3623%, and a debt to equity ratio of 0.1579.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.04% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,104.45 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.17%, reaching the current market price of ₹1,104.80. This ascent signifies increased investor sentiment. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

With a -0.42% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,103.00. The stock is currently trading at a PE of 16.9100, while the industry PE is 33.0184, prompting investors to assess its value proposition.

Following a noteworthy 0.83% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,103.00. When it comes to valuation, this stock has a PE ratio of 16.9100, with the industry PE ratio at 33.0184.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.83% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,103.00 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

With a -0.13% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,094.25. This development raises questions about the factors behind the decline. The stock's PE ratio is 16.9100, while the industry PE is 33.0184.

Demonstrating a commendable 0.41% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,094.55. In terms of valuation, the stock maintains a PE ratio of 16.9100, while the industry PE ratio stands at 33.0184.

Dr Reddys Laboratories Ltd stock price decreased by -0.02%, with the current market value at ₹1,089.30 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd shares saw a -0.14% decrease, reaching a current market price of ₹1,090.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 16.9100, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.22%, signalling a challenging period. Currently trading at ₹1,092.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -0.45% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,095.05. This development raises questions about the factors behind the decline. The stock's PE ratio is 16.9100, while the industry PE is 33.0184.